Such carbohydrate overestimation poses considerable risks (e.g., poor glycaemic control and hypoglycaemic episodes) for patients with diabetes who rely on carbohydrate counting to calculate fixed-dose insulin. The gene discussed is INS; the disease is diabetes mellitus.